| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/03/2003 | WO2003011113A3 Systems and methods for targeted magnetic resonance imaging of the vascular system |
| 07/03/2003 | WO2002101009A3 Structural and cytoskeleton-associated proteins |
| 07/03/2003 | US20030125617 Method of magnetic resonance imaging |
| 07/03/2003 | US20030125376 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 07/03/2003 | US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 07/03/2003 | US20030124059 Imaging agents, precursors thereof and methods of manufacture |
| 07/03/2003 | US20030124056 Carrier molecules |
| 07/03/2003 | US20030121279 Hyperpolarization of a gas |
| 07/03/2003 | CA2470597A1 Artificial bone mineral substitute material containing a ceramic and a water soluble non-ionic x-ray contrast agent |
| 07/02/2003 | EP1323434A2 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 07/02/2003 | EP1323433A1 Compositions for preventing urinary calculus |
| 07/02/2003 | EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322340A2 Manganese complexes for magnetic resonance imaging |
| 07/02/2003 | EP1322339A1 Method for early prediction of the onset of invasive cancer |
| 07/02/2003 | EP1140210B1 Methods and compositions comprising monitoring devices |
| 07/02/2003 | EP0660714B1 Novel liposomal drug delivery systems |
| 07/02/2003 | CN1112935C Microencapsulated fluorinated gas for use as developer |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586008 For delivery to the pulmonary system; particles consist of a therapeutic, prophylactic or diagnostic agent, or any combination thereof, an amino acid or salt thereof, and a phospholipid or combination of phospholipids |
| 07/01/2003 | US6585955 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 07/01/2003 | US6585678 Booster for therapy of disease with ultrasound and pharmaceutical IDLIQU composition containing the same |
| 06/26/2003 | WO2003052106A1 Method of screening compounds |
| 06/26/2003 | WO2003051278A2 Nanoparticle delivery vehicle |
| 06/26/2003 | WO2003005026A3 Chemical capture reagent |
| 06/26/2003 | WO2002046385A3 Enzymes |
| 06/26/2003 | US20030120204 Oxygen delivery agents and uses for the same |
| 06/26/2003 | US20030120151 Magnetic resonance imaging methods and compositions |
| 06/26/2003 | US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives |
| 06/26/2003 | US20030118916 Optic power controller; chromogen modified polymer |
| 06/26/2003 | US20030118610 Oral delivery of peptides using enzyme-cleavable membrane translocators |
| 06/26/2003 | US20030118585 Use of protein biomolecular targets in the treatment and visualization of brain tumors |
| 06/26/2003 | US20030118509 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 06/26/2003 | CA2470311A1 Method of screening compounds |
| 06/26/2003 | CA2453417A1 Nanoparticle delivery vehicle |
| 06/25/2003 | EP1321032A1 Method of constructing heart failure model animal |
| 06/25/2003 | EP1320762A1 Method of magnetic resonance investigation of a sample using a nuclear spin polarised mr imaging agent |
| 06/25/2003 | EP1320548A2 Transporters and ion channels |
| 06/25/2003 | EP1320383A2 Photosensitisers |
| 06/25/2003 | EP1088315B1 Nucleation and growth of magnetic metal oxide nanoparticles and its use |
| 06/25/2003 | EP0697892B1 Method of evaluating chemotherapeutic agents in vivo |
| 06/25/2003 | CN1426307A 蛋白质 Protein |
| 06/24/2003 | US6583334 Ovariectomized mouse model for human menopause |
| 06/24/2003 | US6583333 Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas |
| 06/24/2003 | US6583301 Lipids |
| 06/24/2003 | US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper |
| 06/24/2003 | US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus |
| 06/24/2003 | US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 06/24/2003 | US6581607 Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response |
| 06/24/2003 | US6581606 Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response |
| 06/24/2003 | CA2047142C Skin test to human papillomavirus type 16 |
| 06/19/2003 | WO2003050499A2 Use of a labeled ligand having human cd4 specificity |
| 06/19/2003 | WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity |
| 06/19/2003 | WO2003049728A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 06/19/2003 | WO2003049599A2 Methods and compositions for the diagnosis of asthma |
| 06/19/2003 | WO2002077237A3 Transporters and ion channels |
| 06/19/2003 | WO2002064084A3 In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease |
| 06/19/2003 | US20030114385 Viral enzyme activated prototoxophores and use of same to treat viral infections |
| 06/19/2003 | US20030113824 Dihydroxy unsaturated fatty acid levels as diagnostic markers |
| 06/19/2003 | US20030113819 Carrier peptide and method for delivery of molecules into cells |
| 06/19/2003 | US20030113336 A compound comprising a targeting moiety binds to a chelator, quinolone antibiotics, imaging tumors in a patient, treating cancer |
| 06/19/2003 | US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 06/19/2003 | US20030113267 Visualisation of the intestinal tract by adminstering a contrast agent excreted by the hepatobiliary route in >/= .5% of the dose injected followed by a imaging method |
| 06/19/2003 | US20030113266 Dental plaque taken from a subject is directly applied on to an absorptive material with a pH indicator having an indicator range of pH 3.5-8.0 and a sugar |
| 06/19/2003 | US20030113265 Contrast agents for magnetic resonance imaging |
| 06/19/2003 | US20030113263 Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia |
| 06/19/2003 | US20030113262 Gpib-lipid bond construct and use thereof |
| 06/19/2003 | CA2469901A1 Use of a labelled ligand having specificity for the human cd4 molecule to produce a diagnostic agent for analysing migration and/or distribution patterns of cell populations |
| 06/19/2003 | CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity |
| 06/18/2003 | EP1318992A1 Imidazole derivatives as raf kinase inhibitors |
| 06/18/2003 | EP1318845A1 Hydrophilic, lubricious medical devices having contrast for magnetic resonance imaging |
| 06/18/2003 | EP1263477A4 Simultaneous multimodal measurement of physiological function |
| 06/18/2003 | EP1232247A4 Modulation of signal transduction |
| 06/18/2003 | EP1140829A4 Contrast media for angiography |
| 06/18/2003 | EP0800545B1 Targeted magnetically labeled molecular marker systems for the nmr imaging |
| 06/18/2003 | CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/18/2003 | CN1424919A Microcapsules comprising functionalised polyalkylcyanoacrylates |
| 06/17/2003 | US6580016 Attaching a biocompatible lipid avid agent to a lipid accumulation in a wall of the artery; predicting rupture; atherosclerosis diagnosis |
| 06/17/2003 | US6579719 Detecting polypeptide analytes in a sample by exposing it to an adsorbent and washing unbound polypeptides with a eluant; use in clinical diagnostics and drug discovery |
| 06/17/2003 | US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins |
| 06/17/2003 | US6579523 Transplants for myocardial scars |
| 06/17/2003 | US6579511 Assessment of concentration of inhalational compounds in the brain |
| 06/17/2003 | CA2077712C Process and device for the production of a contrast medium from a concentrate |
| 06/12/2003 | WO2003048774A1 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors |
| 06/12/2003 | WO2003048394A1 Polynucleotides and polypeptides associated with the development of osteoarthritis |
| 06/12/2003 | WO2003048384A2 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms |
| 06/12/2003 | WO2003047594A1 Disease treatment using two related compounds wherein at least one of the compound induces a tachyphylactic response which not affect the other compound |
| 06/12/2003 | WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 06/12/2003 | WO2003047494A2 Reverse micelle compositions and uses thereof |
| 06/12/2003 | US20030110523 Determination genotypes |
| 06/12/2003 | US20030109684 Antitumor agents; transforming growth factor |
| 06/12/2003 | US20030109537 Methods and materials for treating bone conditions |
| 06/12/2003 | US20030109491 Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids |
| 06/12/2003 | US20030109443 Determining the prognosis for treatment of, and methods for identifying candidate compounds for treating, stabilizing, or preventing cancer, for example, endometrial cancer. These methods utilize the novel tumor suppressor protein, Cables. |
| 06/12/2003 | US20030109058 Optical pumping modules, polarized gas blending and dispensing systems, and automated polarized gas distribution systems and related devices and methods |
| 06/12/2003 | US20030108613 Applying a magnetic gradient field in the separation space to the drug preparation flowing through a device integrated into an attachment filter for injection instruments or infusion instruments; no pressure needed; demetallization; purity |
| 06/12/2003 | US20030108611 Bioactive particulates having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery |
| 06/12/2003 | US20030108486 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 06/12/2003 | US20030108485 Automated modular hyperpolarizers and related devices and methods |